Compound Summary
PYRIDOSTIGMINE BROMIDE
Compound Information
PYRIDOSTIGMINE BROMIDE
Compound Name: | PYRIDOSTIGMINE BROMIDE |
Compound CID: | 7550 |
Synonyms: | PYRIDOSTIGMINE BROMIDE 101-26-8 Mestinon Regonol 3-(Dimethylcarbamoyloxy)-1-methylpyridinium Bromide More... |
Iupac Name: | (1-methylpyridin-1-ium-3-yl) N,N-dimethylcarbamate;bromide |
InChI: | InChI=1S/C9H13N2O2.BrH/c1-10(2)9(12)13-8-5-4-6-11(3)7-8;/h4-7H,1-3H3;1H/q+1;/p-1 |
InChIKey: | VNYBTNPBYXSMOO-UHFFFAOYSA-M |
Canonical Smiles: | C[N+]1=CC=CC(=C1)OC(=O)N(C)C.[Br-] |
Isomeric Smiles: | C[N+]1=CC=CC(=C1)OC(=O)N(C)C.[Br-] |
Molecular Weight: | 261.12 |
Molecular Formula: | C9H13BrN2O2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
PYRIDOSTIGMINE BROMIDE
Molecular Weight: | 261.12 |
Molecular Formula: | C9H13BrN2O2 |
Hydrogen Bond Donor Count: | 0 |
Hydrogen Bond Acceptor Count: | 3 |
Rotatable Bond Count: | 2 |
Heavy Atom Count: | 14 |
Complexity: | 183 |
Synonyms
PYRIDOSTIGMINE BROMIDE
| PYRIDOSTIGMINE BROMIDE | PYRIDOSTIGMINE BROMIDE |
|---|---|
PYRIDOSTIGMINE BROMIDE |
101-26-8 |
Mestinon |
Regonol |
3-(Dimethylcarbamoyloxy)-1-methylpyridinium Bromide |
3-((Dimethylcarbamoyl)oxy)-1-methylpyridin-1-ium bromide |
Kalimin |
Kalymin |
Regonal |
Mestinon bromide |
Pyridostigmine (bromide) |
UNII-KVI301NA53 |
(1-methylpyridin-1-ium-3-yl) N,N-dimethylcarbamate;bromide |
MLS000028385 |
3-(dimethylcarbamoyl)oxy-1-methylpyridin-1-ium bromide |
KVI301NA53 |
Pyridinium, 3-(((dimethylamino)carbonyl)oxy)-1-methyl-, bromide |
Pyridinium, 3-(dimethylamino)carbonyloxy-1-methyl-, bromide |
Ro 1-5130 |
MFCD00079283 |
NSC-679759 |
NCGC00094324-02 |
3-(((Dimethylamino)carbonyl)oxy)-1-methylpyridinium bromide |
SMR000058605 |
3-(Dimethylcarbamyloxy)-1-methylpyridinium bromide |
DSSTox_CID_3540 |
1-Methyl-3-hydroxypyridinium bromide dimethylcarbamate |
3-Hydroxy-1-methylpyridinium bromide dimethylcarbamate |
DSSTox_RID_77069 |
DSSTox_GSID_23540 |
Dimethylcarbamic acid ester of 3-hydroxy-1-methylpyridinium bromide |
CHEMBL812 |
Carbamic acid, dimethyl-, ester with 3-hydroxy-1-methylpyridinium bromide |
3-Dimethylcarbamoyloxy-1-methylpyridinium bromide;3-Dimethylcarbamoyloxy-1-methylpyridinium bromide |
CAS-101-26-8 |
Piridostigmina bromuro DCIT |
CCRIS 6798 |
Piridostigmina bromuro |
Pyridostigmini bromidum |
HSDB 3924 |
SR-01000003072 |
Bromure de pyridostigmine |
Bromuro de piridostigmina |
EINECS 202-929-9 |
Pyridostigmini bromidum INN-Latin |
Bromure de pyridostigmine INN-French |
3-{(dimethylamino)carbonyloxy}-1-methylpyridinium bromide |
Bromuro de piridostigmina INN-Spanish |
Mestinon-SR |
Mestinon (TN) |
PyridostigmineBromine |
Pyridinium, 3-hydroxyl-1-methyl-, bromide, dimethylcarbamate |
Opera_ID_420 |
3-Hydroxy-1-methylpyridinium bromide dimethylcarbamate (ester) |
Pyridostigmine bromide USP:INN:BAN:JAN |
SCHEMBL41147 |
MLS001074080 |
SPECTRUM1503240 |
CHEBI:8666 |
DTXSID9023540 |
HMS500K09 |
HY-B0207A |
Pyridostigmine Bromide (Mestinon) |
HMS1922M05 |
HMS2092P14 |
HMS2234D06 |
HMS3259M16 |
HMS3263O11 |
HMS3369P02 |
HMS3651G13 |
HMS3884M21 |
Pharmakon1600-01503240 |
BCP02148 |
Tox21_111266 |
Tox21_501035 |
CCG-40306 |
NSC679759 |
NSC758435 |
Pyridinium, 3-hydroxy-1-methyl-, bromide, dimethylcarbamate (ester) |
s1608 |
AKOS015895321 |
Tox21_111266_1 |
AC-8143 |
LP01035 |
MCULE-9535630272 |
NC00581 |
NSC 758435 |
NSC-758435 |
NCGC00015862-07 |
NCGC00094324-01 |
NCGC00094324-03 |
NCGC00094324-04 |
NCGC00261720-01 |
Pyridostigmine bromide (JP17/USP/INN) |
AS-13164 |
H494 |
AB0013077 |
RO-1-5130 |
EU-0101035 |
FT-0603307 |
P1339 |
ST51015114 |
SW199029-2 |
D00487 |
P 9797 |
T71526 |
Q-201644 |
SR-01000003072-2 |
SR-01000003072-4 |
Q26840825 |
3-(Dimethylaminocarbonyloxy)-1-methylpyridinium bromide |
Z1541632810 |
N,N-dimethyl(1-methyl(3-pyridyloxy))carboxamide, bromide |
Pyridostigmine bromide, European Pharmacopoeia (EP) Reference Standard |
Pyridostigmine bromide, United States Pharmacopeia (USP) Reference Standard |
Experimental Data
PYRIDOSTIGMINE BROMIDE
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | -8.000000000000000 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
PYRIDOSTIGMINE BROMIDE
Statistics Data
PYRIDOSTIGMINE BROMIDE
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -8.000000000000000 | 1 | 1 |
Statistics Data Visualization
PYRIDOSTIGMINE BROMIDE
